JPMORGAN CHASE & CO — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that JPMORGAN CHASE & CO filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $182.45B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $177.56B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $158.10B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $128.70B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $121.65B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $119.95B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $115.72B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $108.78B | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $100.71B | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $96.57B | Feb 26, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $57.05B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $58.47B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $49.55B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $37.68B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $48.33B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $29.13B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $36.43B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $32.47B | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $24.44B | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $24.73B | Feb 26, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($147.78B) | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | ($42.01B) | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $12.97B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $107.12B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $78.08B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | ($79.91B) | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $4.09B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $15.61B | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | ($10.83B) | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $21.88B | Feb 26, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4,424.90B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $4,002.81B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $3,875.39B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $3,665.74B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $3,743.57B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $3,384.76B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $2,686.48B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $2,622.53B | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $2,533.60B | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $2,490.97B | Feb 26, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4,062.46B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $3,658.06B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $3,547.52B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $3,373.41B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $3,449.44B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $3,105.40B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $2,426.05B | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $2,366.02B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $2,277.91B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $2,236.78B | Feb 27, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $362.44B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $344.76B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $327.88B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $292.33B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $294.13B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $279.35B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $261.33B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $256.52B | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $255.69B | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $254.19B | Feb 26, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $52.73B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $52.57B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $52.63B | Feb 13, 2026 |
| FY2025 | Dec 31, 2022 | $51.66B | Feb 13, 2026 |
| FY2024 | Dec 31, 2021 | $50.32B | Feb 14, 2025 |
| FY2023 | Dec 31, 2020 | $49.25B | Feb 16, 2024 |
| FY2022 | Dec 31, 2019 | $47.82B | Feb 21, 2023 |
| FY2021 | Dec 31, 2018 | $47.47B | Feb 22, 2022 |
| FY2020 | Dec 31, 2017 | $47.51B | Feb 23, 2021 |
| FY2019 | Dec 31, 2016 | $47.29B | Feb 25, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $416.06B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $376.17B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $332.90B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $296.46B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $272.27B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $236.99B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $223.21B | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $199.20B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $177.68B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $162.44B | Feb 27, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $278.79B | Feb 26, 2019 |
| FY2018 | Dec 31, 2017 | $431.30B | Feb 26, 2019 |
| FY2018 | Dec 31, 2016 | $391.15B | Feb 26, 2019 |
| FY2018 | Dec 31, 2015 | $361.68B | Feb 26, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $267.89B | Feb 20, 2014 |
| FY2012 | Dec 31, 2012 | $249.02B | Feb 28, 2013 |
| FY2011 | Dec 31, 2011 | $256.78B | Feb 29, 2012 |
| FY2011 | Dec 31, 2010 | $270.65B | Feb 29, 2012 |
| FY2009 | Dec 31, 2009 | $266.32B | Feb 24, 2010 |
| FY2009 | Dec 31, 2008 | $270.68B | Feb 24, 2010 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 20 | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 19 | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | 16 | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | 12 | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | 15 | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | 8 | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | 10 | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | 9 | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | 6 | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | 6 | Feb 26, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 20 | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 19 | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | 16 | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | 12 | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | 15 | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | 8 | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | 10 | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | 9 | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | 6 | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | 6 | Feb 26, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2.70B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 2.80B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | 2.88B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | 2.93B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | 2.94B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | 3.05B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | 3.08B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | 3.28B | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | 3.43B | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | 3.56B | Feb 26, 2019 |